• Теги
    • избранные теги
    • Компании97
      • Показать ещё
      Разное32
      • Показать ещё
      Страны / Регионы30
      • Показать ещё
      Показатели8
      Международные организации4
      Издания6
      Формат1
H Lundbeck
23 марта, 16:47

Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse

We issued an updated research report on Catalyst Pharmaceuticals, Inc. (CPRX) on Mar 22.

07 марта, 17:32

Catalyst Pharma (CPRX): What???s in Store in Q4 Earnings?

Catalyst Pharmaceuticals, Inc. (CPRX) is expected to report fourth-quarter 2016 results this month.

Выбор редакции
Выбор редакции
21 декабря 2016, 12:22

BRIEF-NNIT extends agreement with Lundbeck

* Estimated total value of agreement consisting of three contracts will amount in high double-digit million Danish crown range

25 ноября 2016, 15:00

Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?

Lilly's (LLY) failure has spooked investors who are now wondering whether other anti-amyloid treatments in development will face a similar fate.

08 ноября 2016, 17:30

Cirrus Logic, Skechers, Valeo SA ADR, H Lundbeck AS and Quanta Services highlighted as Zacks Bull and Bear of the Day

Cirrus Logic, Skechers, Valeo SA ADR, H Lundbeck AS and Quanta Services highlighted as Zacks Bull and Bear of the Day

07 ноября 2016, 18:38

12 Fun Facts About U.S. Presidential Elections: Global Week Ahead

Here are 12 facts I found most interesting (or funny!), and relevant to this U.S. election of 2016.

07 ноября 2016, 16:25

Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise?

Catalyst Pharmaceuticals, Inc. (CPRX) is scheduled to report third-quarter 2016 results on Nov 9, after market close.

Выбор редакции
02 ноября 2016, 10:10

Lundbeck climbs 6.1% after rise in 2016 guidance

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
Выбор редакции
24 августа 2016, 15:56

Quick Guide to Oppenheimer International Small-Mid Company Y Fund (OSMYX)

Oppenheimer International Small-Mid Company Y Fund (OSMYX) a Zacks Rank #2 (Buy) was incepted in November 1997 and is managed by Oppenheimer Funds Group

Выбор редакции
04 августа 2016, 01:11

Catalyst (CPRX) Q2 Earnings: Can the Stock Pull a Surprise?

Catalyst Pharmaceuticals, Inc. (CPRX ) is scheduled to report second-quarter 2016 results on Aug 9.

26 июля 2016, 16:02

Lilly (LLY) Beats on Q2 Earnings & Revenue, Maintains View

New products in Lilly's (LLY) portfolio contributed to volume growth in the quarter.

19 июля 2016, 16:34

J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook

Johnson & Johnson's (JNJ) shares were up in pre-market trading with the company beating on all fronts and raising its guidance for 2016.

Выбор редакции
17 июня 2016, 02:46

Don't Make it Complicated, Own Drug Stocks

The Large Cap Pharma Industry usually looks like a solid investor niche. Place a few of your stock picking bets here.

15 июня 2016, 16:30

Zacks Industry Rank Analysis Highlights: Pfizer, Bristol-Myers Squibb and H Lundbeck

Zacks Industry Rank Analysis Highlights: Pfizer, Bristol-Myers Squibb and H Lundbeck

14 июня 2016, 20:37

Don't Make It Complicated, Own Drug Stocks

Don't Make It Complicated, Own Drug Stocks

Выбор редакции
31 мая 2016, 15:46

Why H. Lundbeck (HLUYY) Stock Might be a Great Pick

H. Lundbeck (HLUYY) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.